
|Videos|July 28, 2016
Incorporating Newer Antiemetics in Clinical Practice
Advertisement
Episodes in this series

James Natale, PharmD, BCOP, explains the importance of understanding newer antiemetic options in the changing therapeutic landscape of chemotherapy-induced nausea and vomiting.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Obinutuzumab-Bendamustine Produces High Response Rates in Chinese Patients With Indolent B-Cell Lymphomas
2
State Pharmacy Boards Must Step Up Against Illegal Retatrutide
3
New CKD Outcome Set Tells Pharmacists What to Measure
4
GLP-1s and the HCM–Sleep Apnea–Obesity Connection
5













































































































